Published in Int J Clin Pharmacol Biopharm on March 01, 1977
The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa. J Neurol Neurosurg Psychiatry (1994) 1.07
Bioavailability of dihydroergotamine in man. Br J Clin Pharmacol (1982) 0.82
Low bioavailability as a cause of apparent failure of dihydroergotamine in orthostatic hypotension. Br Med J (1980) 0.81
Ergotamine absorption and toxicity. Postgrad Med J (1982) 0.79
Quantitative determination of ergot alkaloids in biological fluids by radioimmunoassay. Br J Clin Pharmacol (1978) 0.75
Low bioavailability of ergotamine tartrate after oral and rectal administration in migraine sufferers. Br J Clin Pharmacol (1983) 0.75
beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers. Br J Clin Pharmacol (1976) 2.17
A new technique for recording compliance of human hand veins. Br J Clin Pharmacol (1981) 1.80
Blood levels of practolol following intravenous administration. Br J Pharmacol (1970) 1.61
Pharmacokinetics of SMS 201-995 in healthy subjects. Scand J Gastroenterol Suppl (1986) 1.36
Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol. Br J Pharmacol (1973) 1.35
Pharmacokinetic criteria for the evaluation of retard formulations. Eur J Clin Pharmacol (1974) 1.25
Venoconstrictor effect of dihydroergotamine in superficial hand veins. Eur J Clin Pharmacol (1974) 1.15
The influence of beta-adrenoceptor blocking drugs with and without intrinsic sympathomimetic activity on the hormonal responses to hypo- and hyperglycaemia. Br J Clin Pharmacol (1982) 1.15
[Peripheral circulatory effects of ergotamine, dihyroergotamine and 1-methylergotamine on the innevated, perfused hindlimb of the o]. Helv Physiol Pharmacol Acta (1967) 1.11
Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations. Br J Clin Pharmacol (1982) 1.08
Pharmacological experiments in healthy volunteers with bopindolol, a long-acting beta-adrenoceptor blocking drug with partial agonist activity. Br J Clin Pharmacol (1985) 1.08
Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration. Acta Endocrinol (Copenh) (1986) 1.04
The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: the effect on heart rate and the electrocardiogram. Postgrad Med J (1970) 1.03
Pharmacokinetics of oral cyclosporin A (Sandimmun) in healthy subjects. Eur J Clin Pharmacol (1986) 1.01
Pindolol, a beta-adrenoceptor blocking agent with a negligible first-pass effect. Br J Clin Pharmacol (1977) 1.00
Duration of action and plasma levels of beta-adrenoceptor blocking drugs. Arch Int Pharmacodyn Ther (1980) 0.95
Prolonged action of pindolol. Br Med J (1973) 0.94
Pharmacokinetics of unlabelled and 14C-labelled pindolol in uraemia. Eur J Clin Pharmacol (1974) 0.94
A randomised controlled trial of spinal manipulative therapy in acute low back pain. Ann Rheum Dis (2008) 0.93
The effect of a new inotropic agent, DPI 201-106, on systolic time intervals and the electrocardiogram in healthy subjects. Br J Clin Pharmacol (1987) 0.93
Assessment of analgesics in dental surgery outpatients. Eur J Clin Pharmacol (1980) 0.92
Intravenous diazepam in minor oral surgery. Further studies. Br Dent J (1970) 0.91
Use of a linear variable differential transformer to measure compliance of human hand veins in situ [proceedings]. Br J Clin Pharmacol (1979) 0.91
Clinical pharmacology of pindolol. Am Heart J (1982) 0.91
A double-blind trial of synthetic salmon calcitonin in the treatment of acute pancreatitis. Scand J Gastroenterol (1979) 0.90
The influence of anxiety and pain sensitivity on experimental pain in man. Pain (1978) 0.89
Prevalence of cam and pincer-type deformities on hip MRI in an asymptomatic young Swiss female population: a cross-sectional study. Osteoarthritis Cartilage (2013) 0.88
Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis. Eur Respir J (2011) 0.86
The effect of graded doses of practolol on the tachycardia induced by isoprenaline, Valsalva's manoeuvre and exercise. Br J Pharmacol (1970) 0.86
The prevalence of widespread central hypersensitivity in chronic pain patients. Eur J Pain (2013) 0.84
Investigation of the venoconstrictor effect of 8' hydroxydihydroergotamine, the main metabolite of dihydroergotamine, in man. Eur J Clin Pharmacol (1984) 0.84
Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol. Br J Clin Pharmacol (1986) 0.83
Cardiac effects of adrenaline and felypressin as vasoconstrictors in local anaesthesia for oral surgery under diazepam sedation. Br J Anaesth (1970) 0.83
Effects of age and smoking on the pharmacokinetics of pindolol and propranolol. Br J Clin Pharmacol (1982) 0.83
Studies of the effect of natural and synthetic polypeptide type ergot compounds on a peripheral vascular bed. Br J Pharmacol (1969) 0.82
Investigations with beta-adrenoceptor blocking drugs in healthy volunteers. Acta Med Scand Suppl (1977) 0.82
A new technique for recording compliance of human hand veins. 1981. Br J Clin Pharmacol (2004) 0.82
Analgesic activity of propyphenazone in patients with pain following oral surgery. Eur J Clin Pharmacol (1986) 0.82
Methods for studying drug effects on superficial human veins. Methods Find Exp Clin Pharmacol (1985) 0.81
[Influence of salmon calcitonin on acute pancreatitis (author's transl)]. Dtsch Med Wochenschr (1979) 0.81
Comparison of the duration of action of pindolol and slow release oxprenolol in healthy volunteers. Eur J Clin Pharmacol (1978) 0.81
Pharmacokinetic investigation of oral and i.v. dihydroergotamine in healthy subjects. Eur J Clin Pharmacol (1991) 0.81
Absolute bioavailability of digoxin tablets. Arzneimittelforschung (1978) 0.80
[Clinicopharmacological studies with pindolol following intravenous and oral administration]. Adv Clin Pharmacol (1976) 0.80
A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet. Eur J Clin Pharmacol (1981) 0.79
Influence of ergot compounds on compliance of superficial hand veins in man. Postgrad Med J (1976) 0.78
Studies on the venoconstrictor effect of ergot compounds in man. Triangle (1975) 0.78
Absolute bioavailability of digoxin in chronic renal failure. Clin Nephrol (1979) 0.78
Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administration. Eur J Clin Pharmacol (1986) 0.78
An examination chair to measure internal rotation of the hip in routine settings: a validation study. Osteoarthritis Cartilage (2009) 0.78
Activity and duration of action of pindolol and alprenolol compared in healthy volunteers. Eur J Clin Pharmacol (1978) 0.77
Experiments with pindolol (Visken) in healthy volunteers. Med J Aust (1977) 0.76
Direct effects of vasoactive substances on superficial human veins in vivo. Int Angiol (1986) 0.76
Non-migrainous headache for the evaluation of oral analgesics. Br J Clin Pharmacol (1980) 0.76
Pharmacokinetic study with synthetic salmon calcitonin (Sandoz). Z Gastroenterol Verh (1976) 0.76
Pharmacokinetics of isradipine in patients with chronic liver disease. Eur J Clin Pharmacol (1990) 0.76
The acute exercise test for the preliminary evaluation of beta-receptor blocking drugs in angina pectoris. Br J Pharmacol (1969) 0.75
Contrasts between pindolol and propranolol concentration-response relationships. Br J Clin Pharmacol (1985) 0.75
Influence of pizotifen and ergotamine on the venoconstrictor effect of 5-hydroxytryptamine and noradrenaline in man. Eur J Clin Pharmacol (1983) 0.75
Vasovagal faint in the supine position. Br Med J (1970) 0.75
Agonists and antagonists of 5-hydroxytryptamine on venomotor receptors. Adv Neurol (1982) 0.75
[Effect of ergot alkaloids on venous tonus determined in superficial hand veins in situ]. Cardiology (1976) 0.75
Proof of the general validity of Dost's law of corresponding areas. Eur J Clin Pharmacol (1973) 0.75
Bioavailability studies with Digoxin-Sandoz and Lanoxin. Eur J Clin Pharmacol (1975) 0.75
Cyclosporine A capsules: bioavailability and clinical acceptance study in renal transplant patients. Transplant Proc (1988) 0.75
Pharmacokinetic comparison of pindolol 30 mg retard and 15 mg normal tablets. Eur J Clin Pharmacol (1982) 0.75
Analgesic effect of fluproquazone in postoperative patients. Clin Pharmacol Ther (1980) 0.75
[Mucus models for investigation of intestinal absorption mechanisms. 3. A mathematical simulation model of drug diffusion through enteral mucus]. Pharmazie (1992) 0.75
Headache as a model for assessing mild analgesic drugs. J Clin Pharmacol (1980) 0.75
Pharmacokinetics of a long-acting bromocriptine preparation (Parlodel LA) and its effect on release of prolactin and growth hormone. Eur J Clin Pharmacol (1986) 0.75
Exploratory analysis of population pharmacokinetic data from clinical trials with application to isradipine. Clin Pharmacol Ther (1991) 0.75
Bioavailability of digoxin. Lancet (1973) 0.75
Lack of effect of the appetite stimulant pizotifen (BC 105) on the absorption of isonicotinylhydrazine. Eur J Clin Pharmacol (1974) 0.75
Clinical pharmacological studies with the long-acting beta-adrenoceptor blocking drug bopindolol. J Cardiovasc Pharmacol (1986) 0.75
Clinical pharmacology of beta-adrenoceptor blocking drugs possessing partial agonist activity, with special reference to pindolol. J Cardiovasc Pharmacol (1983) 0.75
[Proceedings: Studies on the digoxin resorption in patients with decompensated right cardiac insufficiency]. Schweiz Med Wochenschr (1975) 0.75
Influence of smoking and age on pharmacokinetics of beta-receptor blockers. Gerontology (1982) 0.75